Duke, LabCorp Launch 'Factory' to Translate Biomarkers into Personalized Medicine Tests
April 28, 2010
Duke, LabCorp Launch 'Factory' to Translate Biomarkers into Personalized Medicine Tests
The Biomarker Factory, launched earlier this month, enjoins Duke University Medical Center's expertise in biomarker discovery and LabCorp's capacity to develop laboratory-developed tests from validated biomarkers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Snippets
March 4, 2009 / Pharmacogenomics Reporter - Ariosa, LabCorp File Motion to Dismiss Patent Infringement Suit Filed by Verinata
January 23, 2013 / Clinical Sequencing News - Hearing on Second-Opinion Genetic Testing Highlights Risks of Athena's Exclusive Licensing Practices
January 16, 2013 / Pharmacogenomics Reporter - In Brief This Week: Mitomics, Sterling Pathology National Laboratories; J. Craig Venter Institute, CLC Bio; LabCorp
January 11, 2013 / GenomeWeb Daily News - MDx/CDx Focus: Verastem, LabCorp Ink CDx Pact; Foundation Medicine Raises More Cash; and more
January 9, 2013 / Pharmacogenomics Reporter